- Home
- MCRB vs VIOT Comparison
MCRB vs VIOT Comparison
Compare MCRB & VIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- VIOT
- Stock Information
- Founded
- MCRB 2010
- VIOT 2014
- Country
- MCRB United States
- VIOT China
- Employees
- MCRB N/A
- VIOT N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- VIOT Consumer Electronics/Appliances
- Sector
- MCRB Health Care
- VIOT Consumer Discretionary
- Exchange
- MCRB Nasdaq
- VIOT Nasdaq
- Market Cap
- MCRB 103.7M
- VIOT 92.1M
- IPO Year
- MCRB 2015
- VIOT 2018
- Fundamental
- Price
- MCRB $12.09
- VIOT $2.90
- Analyst Decision
- MCRB Hold
- VIOT
- Analyst Count
- MCRB 4
- VIOT 0
- Target Price
- MCRB $73.67
- VIOT N/A
- AVG Volume (30 Days)
- MCRB 109.0K
- VIOT 1.7M
- Earning Date
- MCRB 08-12-2025
- VIOT 08-25-2025
- Dividend Yield
- MCRB N/A
- VIOT N/A
- EPS Growth
- MCRB N/A
- VIOT N/A
- EPS
- MCRB 8.98
- VIOT 0.13
- Revenue
- MCRB N/A
- VIOT $290,307,298.00
- Revenue This Year
- MCRB N/A
- VIOT $15.62
- Revenue Next Year
- MCRB N/A
- VIOT $12.98
- P/E Ratio
- MCRB $1.50
- VIOT $9.96
- Revenue Growth
- MCRB N/A
- VIOT N/A
- 52 Week Low
- MCRB $6.53
- VIOT $0.83
- 52 Week High
- MCRB $30.60
- VIOT $3.55
- Technical
- Relative Strength Index (RSI)
- MCRB 66.74
- VIOT 78.21
- Support Level
- MCRB $10.67
- VIOT $2.26
- Resistance Level
- MCRB $12.84
- VIOT $3.09
- Average True Range (ATR)
- MCRB 1.09
- VIOT 0.31
- MACD
- MCRB 0.34
- VIOT 0.17
- Stochastic Oscillator
- MCRB 85.98
- VIOT 71.74
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About VIOT Viomi Technology Co. Ltd
Viomi Technology Co Ltd along with its subsidiaries provides Internet of Things (IoT) enabled smart home products through its platform. It has developed an IoT Home platform, consisting of an ecosystem of IoT Home portfolio, and home water solutions, together with a suite of complementary consumable products and small appliances and others. Its product offerings include Smart kitchen products like refrigerators, oven steamers, dishwashers, and gas stoves, Other smart products such as air conditioning systems, washing machines, water heaters, smart water kettles, interactive smart screens and other smart devices, and Home water solutions include self-branded and Xiaomi-branded smart water purifiers.